Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Haemonetics Corp. buy Barrington Research

Start price
€81.50
03.11.23 / 50%
Target price
€97.80
03.11.24
Performance (%)
3.68%
Price
€84.50
26.04.24
Summary
This prediction is currently active. The BUY prediction by Barrington_Research shows slight gains of 3.68%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Haemonetics Corp. 11.921% 11.921%
iShares Core DAX® 2.594% -1.861%
iShares Nasdaq 100 3.553% -2.064%
iShares Nikkei 225® 0.687% -8.704%
iShares S&P 500 2.209% -1.988%

Comments by Barrington_Research for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) 3.68%
Target price 97.797
Change
Ends at 03.11.24

Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $114.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat

Stopped prediction by Barrington_Research for Haemonetics Corp.

buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€78.50
12.04.24
€98.71
12.04.25
4.46%
26.04.24

buy
Haemonetics Corp.

Start price
Target price
Perf. (%)
€66.00
13.02.24
€97.90
13.02.25
28.03%
26.04.24